Peregrine Pharmaceuticals (NASDAQ: PPHM) said during the course of preparing for an end-of-phase II meeting with regulatory authorities and following ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE